WallStreetZenWallStreetZen

NYSE: QGEN
Qiagen Nv Earnings & Revenue

OverviewForecastEarnings
DividendOwnership

QGEN past earnings growth

How has QGEN's earnings growth performed historically?
Company
-19.35%
Industry
-10.97%
Market
107.96%
QGEN's earnings have grown slower... subscribe to Premium to read more.
Earnings Growth vs Industry Performance
QGEN's earnings have grown slower... subscribe to Premium to read more.
Earnings Growth vs Market Performance
QGEN's earnings growth is slowing... subscribe to Premium to read more.
Accelerating Earnings Growth Performance

QGEN past revenue growth

How has QGEN's revenue growth performed historically?
Company
-8.23%
Industry
0.45%
Market
17.57%
QGEN's revenue has grown slower... subscribe to Premium to read more.
Revenue Growth vs Industry Performance
QGEN's revenue has grown slower... subscribe to Premium to read more.
Revenue Growth vs Market Performance
QGEN's revenue growth is slowing... subscribe to Premium to read more.
Accelerating Revenue Growth Performance

QGEN earnings and revenue history

Current Revenue
$2.0B
Current Earnings
$341.3M
Current Profit Margin
17.4%
QGEN's has demonstrated consistent long-term... subscribe to Premium to read more.
Long-term Earnings Growth Trend Performance

QGEN Return on Equity

Current Company
9.3%
Current Industry
-24%
Current Market
188%
QGEN's Return on Equity (9.3%)... subscribe to Premium to read more.
High Return on Equity Performance

Be the first to know when QGEN announces earnings.

QGEN Return on Assets

Current Company
5.5%
Current Industry
6.7%
QGEN is generating lower Return... subscribe to Premium to read more.
Above Average Return on Assets Performance

QGEN Return on Capital Employed

Current Company
9.6%
Current Industry
11.6%
QGEN has gotten more efficient... subscribe to Premium to read more.
Increasing Return on Capital Employed Performance

QGEN vs Diagnostic & Research Stocks

TickerRevenueEBITDAEarningsY/Y RevenueY/Y Earnings
QGEN$1.97B$688.56M$341.30M+5.53%+11.61%
NTRA$1.08B-$383.28M-$434.80M+33.26%N/A
EXAS$2.50B$52.20M-$204.15M+40.63%N/A
MEDP$1.89B$382.14M$282.81M+21.76%+35.02%
CRL$4.13B$1.03B$474.62M+12.75%+14.45%
View Top Diagnostic & Research Stocks

QGEN earnings dates

Next earnings date
Apr 30, 2024

Qiagen Nv Earnings & Revenue FAQ

What were QGEN's earnings last quarter?

On Invalid Date, Qiagen Nv (NYSE: QGEN) reported Q4 2023 earnings per share (EPS) of $0.40, up 15.07% year over year. Total Qiagen Nv earnings for the quarter were $97.66 million. In the same quarter last year, Qiagen Nv's earnings per share (EPS) was $0.35.

If you're new to stock investing, here's how to buy Qiagen Nv stock.

What was QGEN's earnings growth in the past year?

As of Q2 2024, Qiagen Nv's earnings has grown -19.35% year over year. This is 8.38 percentage points lower than the US Diagnostics & Research industry earnings growth rate of -10.97%. Qiagen Nv's earnings in the past year totalled $341.30 million.

What is QGEN's earnings date?

Qiagen Nv's earnings date is Invalid Date. Add QGEN to your watchlist to be reminded of QGEN's next earnings announcement.

What was QGEN's revenue last quarter?

On Invalid Date, Qiagen Nv (NYSE: QGEN) reported Q4 2023 revenue of $509.16 million up 2.24% year over year. In the same quarter last year, Qiagen Nv's revenue was $497.98 million.

What was QGEN's revenue growth in the past year?

As of Q2 2024, Qiagen Nv's revenue has grown -8.23% year over year. This is 8.68 percentage points lower than the US Diagnostics & Research industry revenue growth rate of 0.45%. Qiagen Nv's revenue in the past year totalled $1.97 billion.
©2024 WallStreetZen
Company
AboutNewsBlogStock Investing FAQPlansPrivacy PolicyTerms of ServiceCancellation & RefundsHelp GuidesContactTwitterYouTubeNewsletter
Stock Tools
Top Performing AnalystsStock ScreenerStock ForecastTrending StocksStrong Buy StocksHighest Earnings StocksBest Dividend Paying StocksStatisticsStock Market SectorsStock Market IndustriesHow to Buy Stocks Online
Stock Ideas
Buy The DipBiggest Stock Gainers TodayBiggest Stock Losers Today52 Week High Stocks52 Week Low StocksMost Active Stocks TodayMost Undervalued StocksBest Penny Stocks to Buy NowBest Stocks Under $5Best Stocks Under $10
WallStreetZen does not provide financial advice and does not issue recommendations or offers to buy stock or sell any security.

Information is provided 'as-is' and solely for informational purposes and is not advice. WallStreetZen does not bear any responsibility for any losses or damage that may occur as a result of reliance on this data.